  Black Americans with and without Using data from the African-American Study of Kidney Disease and Hypertension , a multicenter clinical trial followed by a cohort phase with a median total follow-up of 9.7 years ( interquartile range , 6.5-10.9 years) , we examined the associations of suPAR with CKD progression ( defined as doubling of serum creatinine or ESKD) , ESKD , worsening proteinuria<symptom> ( defined as pre-ESKD doubling of 24-hour urine protein-to-creatinine ratio to â‰¥ 220 mg/g) , and all-cause death. At baseline , the median suPAR was 4462 pg/ml , mean measured GFR was 46 ml/min per 1.73 m Higher suPAR was associated with various adverse outcomes in Black Americans with CKD , with and without